BAGE2 Polyclonal Antibody

Unknown. Candidate gene encoding tumor antigens.,miscellaneous:The ancestral BAGE gene was generated by juxtacentromeric reshuffling of the MLL3 gene. The BAGE family was expanded by juxtacentromeric movement and/or acrocentric exchanges. BAGE family is composed of expressed genes that map to the juxtacentromeric regions of chromosomes 13 and 21 and of unexpressed gene fragments that scattered in the juxtacentromeric regions of several chromosomes, including chromosomes 9, 13, 18 and 21.,Belongs to the BAGE family.,tissue specificity:Not expressed in normal tissues except in testis. Expressed in 22% of melanomas, in bladder and lung carcinomas.,tissue specificity:Not expressed in normal tissues except in testis. Expressed in melanoma, bladder and lung carcinomas.,

Introducing the BAGE2 Polyclonal Antibody, meticulously developed by BT Lab, a renowned name in the field of biotechnology. This cutting-edge product is designed to cater to the diverse needs of researchers and scientists in their quest for unravelling the mysteries of biology.

The BAGE2 Polyclonal Antibody is a result of rigorous research and development, ensuring its exceptional quality and reliability. With its high specificity and sensitivity, this antibody offers an invaluable tool for the detection and analysis of BAGE2 protein expression in various biological samples.

Crafted with utmost precision, this antibody exhibits an affinity towards BAGE2, a protein associated with tumorigenesis and cancer progression. Its ability to recognize and bind to BAGE2 with utmost accuracy enables researchers to explore its role in cancer biology, paving the way for potential therapeutic interventions.

The BAGE2 Polyclonal Antibody boasts an array of remarkable features that set it apart from its counterparts. Its exceptional performance in immunohistochemistry (IHC), immunofluorescence (IF), and western blotting techniques ensures reliable and reproducible results. This antibody's versatility allows for its application in a wide range of research areas, including cancer biology, molecular biology, and immunology.

Furthermore, the BAGE2 Polyclonal Antibody is manufactured using state-of-the-art techniques and undergoes stringent quality control measures to guarantee its consistency and effectiveness. Its formulation ensures stability and longevity, enabling researchers to conduct experiments with confidence and accuracy.

In summary, the BAGE2 Polyclonal Antibody by BT Lab is a remarkable scientific tool that empowers researchers to delve deeper into the intricate world of cancer biology. With its exceptional specificity, sensitivity, and versatility, this antibody promises to revolutionize the field of biomedical research. Trust in the BAGE2 Polyclonal Antibody to unlock new insights and drive groundbreaking discoveries in the realm of biology.